8 Even if you can afford treatment, getting the drugs is another story
Semaglutide itself is a glucagon-like peptide-1 (GLP-1) receptor agonist that has attracted significant attention in the research community for its role in metabolic pathway studies, receptor binding analyses, and cellular signaling investigations
10.1111/obr.12843 101
The measures differ across rows, including hippocampal volume, dementia risk, clinical decline, and an aging clock, so the bars are not strictly comparable, and a larger bar reflects a larger measured effect rather than stronger evidence
In patients who are unable to tolerate an increased dose during escalation, the prescriber should consider delaying the next dose increase for ~1 additional week
They can evaluate your individual and family health history, goals, and other medications to help determine if treatment with tirzepatide or semaglutide is right for you